1.
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
by Marathe, Chinmay S.
Experimental diabetes research, 2011-06-22, Vol.2011, p.279530-10

2.
The Role of Metformin in the Management of NAFLD
by Mazza, Angela
Experimental diabetes research, 2011-12-12, Vol.2012, p.716404-13

3.
The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient
by Lorenzi, Mara
Experimental diabetes research, 2007, Vol.2007, p.61038-10

4.
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
by Willard, Francis S.
Experimental diabetes research, 2012-05-14, Vol.2012, p.470851-12

5.
Mitochondrial Dysfunction and β-Cell Failure in Type 2 Diabetes Mellitus
by Ma, Zhongmin Alex
Experimental diabetes research, 2011-11-09, Vol.2012, p.703538-11

6.
Impact of Maternal Diabetes on Epigenetic Modifications Leading to Diseases in the Offspring
by Vrachnis, Nikolaos
Experimental diabetes research, 2012-11-20, Vol.2012, p.538474-6

7.
Maternal Diabetes in Pregnancy: Early and Long-Term Outcomes on the Offspring and the Concept of “Metabolic Memory”
by Yessoufou, Akadiri
Experimental diabetes research, 2011-11-21, Vol.2011, p.218598-12

8.
Obesity and Appetite Control
by Suzuki, Keisuke
Experimental diabetes research, 2012-08-01, Vol.2012, p.824305-19

9.
A Review on the Association between Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer
by Chiu, Wei-Yih
Experimental diabetes research, 2012-05-28, Vol.2012, p.924168-7

10.
Diabetes and Thyroid Cancer Risk: Literature Review
by Shih, Shyang-Rong
Experimental diabetes research, 2012-06-12, Vol.2012, p.578285-7

11.
Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms
by Arcidiacono, Biagio
Experimental diabetes research, 2012-06-04, Vol.2012, p.789174-12

12.
Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic...
by Nielsen, Lotte B.
Experimental diabetes research, 2012-07-05, Vol.2012, p.1-7

13.
Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases
by Kumar, Manoj
Experimental diabetes research, 2012-04-30, Vol.2012, p.902917-14

14.
Aspects of Inflammation and Oxidative Stress in Pediatric Obesity and Type 1 Diabetes: An Overview of Ten Years of Studies
by Tran, Brian
Experimental diabetes research, 2012-10-11, Vol.2012, p.683680-7

15.
Development of a Nongenetic Mouse Model of Type 2 Diabetes
by Gilbert, Elizabeth R.
Experimental diabetes research, 2011-11-29, Vol.2011, p.416254-12

16.
Impact of GLP-1 Receptor Agonists on Major Gastrointestinal Disorders for Type 2 Diabetes Mellitus: A Mixed Treatment Comparison Meta-Analysis
by Sun, Feng
Experimental diabetes research, 2012-12-25, Vol.2012, p.230624-14

17.
Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy
by Kern, Timothy S
Experimental diabetes research, 2007, Vol.2007, p.95103-14

18.
Prostate Carcinogenesis with Diabetes and Androgen-Deprivation-Therapy-Related Diabetes: An Update
by Hara, Noboru
Experimental diabetes research, 2012-06-26, Vol.2012, p.801610-8

19.
The Metabolic Syndrome, Oxidative Stress, Environment, and Cardiovascular Disease: The Great Exploration
by Hutcheson, Rebecca
Experimental diabetes research, 2012-07-09, Vol.2012, p.271028-13

20.
Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-Syndrome-Related Risk of Coronary Artery Disease
by Martinelli, Nicola
Experimental diabetes research, 2011-09-22, Vol.2012, p.231502-9
